Summary

The global market for Bedsore Medicine was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2055 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
Bedsore drugs refer to a class of drugs and care products used to prevent, treat and manage skin and subcutaneous tissue damage caused by long-term pressure. These drugs and products are designed to reduce pain, control infection, promote wound healing, and minimize complications. Focus on statistics of patients in the most commonly used bedsore dressing and antibiotics.
The current state of the bedsore medicine market is characterized by a growing demand, particularly in the context of an aging population, leading to an increasing number of bedridden patients and consequently a higher need for bedsore prevention and treatment products. In recent years, with advancements in medical technology and continuous optimization of treatment methods, bedsore medicines have not only diversified in terms of options but have also seen significant improvements in efficacy. The market is currently dominated by companies specializing in the production of bedsore dressings and antibiotic ointments, with healthcare institutions and nursing homes being the main application areas.
Looking towards future trends, the market is expected to become more diversified and personalized, driven by innovations in medical technology, especially the development of new types of dressings and topical treatment medications. The integration of biomaterials and smart technologies has made treatments more precise, accelerating recovery times. Additionally, the promotion of preventative measures, such as smart mattresses and pressure ulcer monitoring devices, will play a crucial role in reducing the incidence of bedsores.
However, the market faces both driving forces and obstacles. The aging global population and the increasing number of chronic disease patients provide strong demand for bedsore treatments. Furthermore, the growing emphasis on patient care quality in healthcare institutions and supportive policies contribute to market development. On the other hand, the high cost of medical treatments and products could pose a barrier to widespread adoption, especially in low-income countries. Additionally, the variability in treatment effectiveness and the need for individualized care presents challenges for product development and clinical application.
This report aims to provide a comprehensive presentation of the global market for Bedsore Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bedsore Medicine by region & country, by Type, and by Application.
The Bedsore Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bedsore Medicine.
Market Segmentation
By Company
3M
Mölnlycke
Smith & Nephew
Convatec
B. Braun
Paul Hartmann
Coloplast
Urgo Group
Cardinal Health
Medline Industries
Foryou Medical
Topmedical
Glenmark Pharmaceuticals
Glaxosmithkline
Sino-American Tianjin SmithKline
Hubei Renfu Chengtian Pharmaceutical
Hangzhou Zhuyangxin Pharmaceutical
Padagis
Front Pharmaceutical
NIPRO JMI Pharma
Taro Pharmaceutical
Teva Pharmaceuticals
Prati-Donaduzzi
Unilab
Encube Ethicals
Bright Future Pharmaceutical
Hengjian Pharmaceutical
Square Pharmaceuticals
Segment by Type
Dressing
Antibiotic Ointment
Segment by Application
Hospital
Clinic
Pharmacy
Online
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bedsore Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bedsore Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bedsore Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Bedsore Medicine Product Introduction
1.2 Global Bedsore Medicine Market Size Forecast
1.2.1 Global Bedsore Medicine Sales Value (2020-2031)
1.2.2 Global Bedsore Medicine Sales Volume (2020-2031)
1.2.3 Global Bedsore Medicine Sales Price (2020-2031)
1.3 Bedsore Medicine Market Trends & Drivers
1.3.1 Bedsore Medicine Industry Trends
1.3.2 Bedsore Medicine Market Drivers & Opportunity
1.3.3 Bedsore Medicine Market Challenges
1.3.4 Bedsore Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bedsore Medicine Players Revenue Ranking (2024)
2.2 Global Bedsore Medicine Revenue by Company (2020-2025)
2.3 Global Bedsore Medicine Players Sales Volume Ranking (2024)
2.4 Global Bedsore Medicine Sales Volume by Company Players (2020-2025)
2.5 Global Bedsore Medicine Average Price by Company (2020-2025)
2.6 Key Manufacturers Bedsore Medicine Manufacturing Base and Headquarters
2.7 Key Manufacturers Bedsore Medicine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bedsore Medicine
2.9 Bedsore Medicine Market Competitive Analysis
2.9.1 Bedsore Medicine Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Bedsore Medicine Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bedsore Medicine as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dressing
3.1.2 Antibiotic Ointment
3.2 Global Bedsore Medicine Sales Value by Type
3.2.1 Global Bedsore Medicine Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Bedsore Medicine Sales Value, by Type (2020-2031)
3.2.3 Global Bedsore Medicine Sales Value, by Type (%) (2020-2031)
3.3 Global Bedsore Medicine Sales Volume by Type
3.3.1 Global Bedsore Medicine Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Bedsore Medicine Sales Volume, by Type (2020-2031)
3.3.3 Global Bedsore Medicine Sales Volume, by Type (%) (2020-2031)
3.4 Global Bedsore Medicine Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Pharmacy
4.1.4 Online
4.2 Global Bedsore Medicine Sales Value by Application
4.2.1 Global Bedsore Medicine Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Bedsore Medicine Sales Value, by Application (2020-2031)
4.2.3 Global Bedsore Medicine Sales Value, by Application (%) (2020-2031)
4.3 Global Bedsore Medicine Sales Volume by Application
4.3.1 Global Bedsore Medicine Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Bedsore Medicine Sales Volume, by Application (2020-2031)
4.3.3 Global Bedsore Medicine Sales Volume, by Application (%) (2020-2031)
4.4 Global Bedsore Medicine Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Bedsore Medicine Sales Value by Region
5.1.1 Global Bedsore Medicine Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Bedsore Medicine Sales Value by Region (2020-2025)
5.1.3 Global Bedsore Medicine Sales Value by Region (2026-2031)
5.1.4 Global Bedsore Medicine Sales Value by Region (%), (2020-2031)
5.2 Global Bedsore Medicine Sales Volume by Region
5.2.1 Global Bedsore Medicine Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Bedsore Medicine Sales Volume by Region (2020-2025)
5.2.3 Global Bedsore Medicine Sales Volume by Region (2026-2031)
5.2.4 Global Bedsore Medicine Sales Volume by Region (%), (2020-2031)
5.3 Global Bedsore Medicine Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Bedsore Medicine Sales Value, 2020-2031
5.4.2 North America Bedsore Medicine Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Bedsore Medicine Sales Value, 2020-2031
5.5.2 Europe Bedsore Medicine Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Bedsore Medicine Sales Value, 2020-2031
5.6.2 Asia Pacific Bedsore Medicine Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Bedsore Medicine Sales Value, 2020-2031
5.7.2 South America Bedsore Medicine Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bedsore Medicine Sales Value, 2020-2031
5.8.2 Middle East & Africa Bedsore Medicine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bedsore Medicine Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Bedsore Medicine Sales Value and Sales Volume
6.2.1 Key Countries/Regions Bedsore Medicine Sales Value, 2020-2031
6.2.2 Key Countries/Regions Bedsore Medicine Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Bedsore Medicine Sales Value, 2020-2031
6.3.2 United States Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Bedsore Medicine Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Bedsore Medicine Sales Value, 2020-2031
6.4.2 Europe Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Bedsore Medicine Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Bedsore Medicine Sales Value, 2020-2031
6.5.2 China Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.5.3 China Bedsore Medicine Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Bedsore Medicine Sales Value, 2020-2031
6.6.2 Japan Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Bedsore Medicine Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Bedsore Medicine Sales Value, 2020-2031
6.7.2 South Korea Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Bedsore Medicine Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Bedsore Medicine Sales Value, 2020-2031
6.8.2 Southeast Asia Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Bedsore Medicine Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Bedsore Medicine Sales Value, 2020-2031
6.9.2 India Bedsore Medicine Sales Value by Type (%), 2024 VS 2031
6.9.3 India Bedsore Medicine Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 3M
7.1.1 3M Company Information
7.1.2 3M Introduction and Business Overview
7.1.3 3M Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 3M Bedsore Medicine Product Offerings
7.1.5 3M Recent Development
7.2 Mölnlycke
7.2.1 Mölnlycke Company Information
7.2.2 Mölnlycke Introduction and Business Overview
7.2.3 Mölnlycke Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mölnlycke Bedsore Medicine Product Offerings
7.2.5 Mölnlycke Recent Development
7.3 Smith & Nephew
7.3.1 Smith & Nephew Company Information
7.3.2 Smith & Nephew Introduction and Business Overview
7.3.3 Smith & Nephew Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Smith & Nephew Bedsore Medicine Product Offerings
7.3.5 Smith & Nephew Recent Development
7.4 Convatec
7.4.1 Convatec Company Information
7.4.2 Convatec Introduction and Business Overview
7.4.3 Convatec Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Convatec Bedsore Medicine Product Offerings
7.4.5 Convatec Recent Development
7.5 B. Braun
7.5.1 B. Braun Company Information
7.5.2 B. Braun Introduction and Business Overview
7.5.3 B. Braun Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 B. Braun Bedsore Medicine Product Offerings
7.5.5 B. Braun Recent Development
7.6 Paul Hartmann
7.6.1 Paul Hartmann Company Information
7.6.2 Paul Hartmann Introduction and Business Overview
7.6.3 Paul Hartmann Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Paul Hartmann Bedsore Medicine Product Offerings
7.6.5 Paul Hartmann Recent Development
7.7 Coloplast
7.7.1 Coloplast Company Information
7.7.2 Coloplast Introduction and Business Overview
7.7.3 Coloplast Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Coloplast Bedsore Medicine Product Offerings
7.7.5 Coloplast Recent Development
7.8 Urgo Group
7.8.1 Urgo Group Company Information
7.8.2 Urgo Group Introduction and Business Overview
7.8.3 Urgo Group Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Urgo Group Bedsore Medicine Product Offerings
7.8.5 Urgo Group Recent Development
7.9 Cardinal Health
7.9.1 Cardinal Health Company Information
7.9.2 Cardinal Health Introduction and Business Overview
7.9.3 Cardinal Health Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Cardinal Health Bedsore Medicine Product Offerings
7.9.5 Cardinal Health Recent Development
7.10 Medline Industries
7.10.1 Medline Industries Company Information
7.10.2 Medline Industries Introduction and Business Overview
7.10.3 Medline Industries Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Medline Industries Bedsore Medicine Product Offerings
7.10.5 Medline Industries Recent Development
7.11 Foryou Medical
7.11.1 Foryou Medical Company Information
7.11.2 Foryou Medical Introduction and Business Overview
7.11.3 Foryou Medical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Foryou Medical Bedsore Medicine Product Offerings
7.11.5 Foryou Medical Recent Development
7.12 Topmedical
7.12.1 Topmedical Company Information
7.12.2 Topmedical Introduction and Business Overview
7.12.3 Topmedical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Topmedical Bedsore Medicine Product Offerings
7.12.5 Topmedical Recent Development
7.13 Glenmark Pharmaceuticals
7.13.1 Glenmark Pharmaceuticals Company Information
7.13.2 Glenmark Pharmaceuticals Introduction and Business Overview
7.13.3 Glenmark Pharmaceuticals Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Glenmark Pharmaceuticals Bedsore Medicine Product Offerings
7.13.5 Glenmark Pharmaceuticals Recent Development
7.14 Glaxosmithkline
7.14.1 Glaxosmithkline Company Information
7.14.2 Glaxosmithkline Introduction and Business Overview
7.14.3 Glaxosmithkline Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Glaxosmithkline Bedsore Medicine Product Offerings
7.14.5 Glaxosmithkline Recent Development
7.15 Sino-American Tianjin SmithKline
7.15.1 Sino-American Tianjin SmithKline Company Information
7.15.2 Sino-American Tianjin SmithKline Introduction and Business Overview
7.15.3 Sino-American Tianjin SmithKline Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Sino-American Tianjin SmithKline Bedsore Medicine Product Offerings
7.15.5 Sino-American Tianjin SmithKline Recent Development
7.16 Hubei Renfu Chengtian Pharmaceutical
7.16.1 Hubei Renfu Chengtian Pharmaceutical Company Information
7.16.2 Hubei Renfu Chengtian Pharmaceutical Introduction and Business Overview
7.16.3 Hubei Renfu Chengtian Pharmaceutical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Hubei Renfu Chengtian Pharmaceutical Bedsore Medicine Product Offerings
7.16.5 Hubei Renfu Chengtian Pharmaceutical Recent Development
7.17 Hangzhou Zhuyangxin Pharmaceutical
7.17.1 Hangzhou Zhuyangxin Pharmaceutical Company Information
7.17.2 Hangzhou Zhuyangxin Pharmaceutical Introduction and Business Overview
7.17.3 Hangzhou Zhuyangxin Pharmaceutical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Hangzhou Zhuyangxin Pharmaceutical Bedsore Medicine Product Offerings
7.17.5 Hangzhou Zhuyangxin Pharmaceutical Recent Development
7.18 Padagis
7.18.1 Padagis Company Information
7.18.2 Padagis Introduction and Business Overview
7.18.3 Padagis Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Padagis Bedsore Medicine Product Offerings
7.18.5 Padagis Recent Development
7.19 Front Pharmaceutical
7.19.1 Front Pharmaceutical Company Information
7.19.2 Front Pharmaceutical Introduction and Business Overview
7.19.3 Front Pharmaceutical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Front Pharmaceutical Bedsore Medicine Product Offerings
7.19.5 Front Pharmaceutical Recent Development
7.20 NIPRO JMI Pharma
7.20.1 NIPRO JMI Pharma Company Information
7.20.2 NIPRO JMI Pharma Introduction and Business Overview
7.20.3 NIPRO JMI Pharma Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 NIPRO JMI Pharma Bedsore Medicine Product Offerings
7.20.5 NIPRO JMI Pharma Recent Development
7.21 Taro Pharmaceutical
7.21.1 Taro Pharmaceutical Company Information
7.21.2 Taro Pharmaceutical Introduction and Business Overview
7.21.3 Taro Pharmaceutical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Taro Pharmaceutical Bedsore Medicine Product Offerings
7.21.5 Taro Pharmaceutical Recent Development
7.22 Teva Pharmaceuticals
7.22.1 Teva Pharmaceuticals Company Information
7.22.2 Teva Pharmaceuticals Introduction and Business Overview
7.22.3 Teva Pharmaceuticals Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Teva Pharmaceuticals Bedsore Medicine Product Offerings
7.22.5 Teva Pharmaceuticals Recent Development
7.23 Prati-Donaduzzi
7.23.1 Prati-Donaduzzi Company Information
7.23.2 Prati-Donaduzzi Introduction and Business Overview
7.23.3 Prati-Donaduzzi Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 Prati-Donaduzzi Bedsore Medicine Product Offerings
7.23.5 Prati-Donaduzzi Recent Development
7.24 Unilab
7.24.1 Unilab Company Information
7.24.2 Unilab Introduction and Business Overview
7.24.3 Unilab Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 Unilab Bedsore Medicine Product Offerings
7.24.5 Unilab Recent Development
7.25 Encube Ethicals
7.25.1 Encube Ethicals Company Information
7.25.2 Encube Ethicals Introduction and Business Overview
7.25.3 Encube Ethicals Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.25.4 Encube Ethicals Bedsore Medicine Product Offerings
7.25.5 Encube Ethicals Recent Development
7.26 Bright Future Pharmaceutical
7.26.1 Bright Future Pharmaceutical Company Information
7.26.2 Bright Future Pharmaceutical Introduction and Business Overview
7.26.3 Bright Future Pharmaceutical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.26.4 Bright Future Pharmaceutical Bedsore Medicine Product Offerings
7.26.5 Bright Future Pharmaceutical Recent Development
7.27 Hengjian Pharmaceutical
7.27.1 Hengjian Pharmaceutical Company Information
7.27.2 Hengjian Pharmaceutical Introduction and Business Overview
7.27.3 Hengjian Pharmaceutical Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.27.4 Hengjian Pharmaceutical Bedsore Medicine Product Offerings
7.27.5 Hengjian Pharmaceutical Recent Development
7.28 Square Pharmaceuticals
7.28.1 Square Pharmaceuticals Company Information
7.28.2 Square Pharmaceuticals Introduction and Business Overview
7.28.3 Square Pharmaceuticals Bedsore Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
7.28.4 Square Pharmaceuticals Bedsore Medicine Product Offerings
7.28.5 Square Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Bedsore Medicine Industrial Chain
8.2 Bedsore Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bedsore Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Bedsore Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer